
To find 25,000 participants to enroll in all the approved trials, researchers would have to begin by approaching more than 37 million people with early memory loss. GINA KOLATA https://ift.tt/2JMWGmJ https://ift.tt/2LHBgJE The New York Times Health Alzheimer's Disease, Clinical Trials, Memory, Elderly July 23, 2018 at 12:00AM
Comments
Post a Comment